AAAAAA
Results: 1-25/39
Authors:
SHEPHERD FA
BEAULIEU R
GELMON K
THUOT CA
SAWKA C
READ S
SINGER J
Citation: Fa. Shepherd et al., PROSPECTIVE RANDOMIZED TRIAL OF 2 DOSE LEVELS OF INTERFERON-ALPHA WITH ZIDOVUDINE FOR THE TREATMENT OF KAPOSIS-SARCOMA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A CANADIAN HIV CLINICAL-TRIALS NETWORK STUDY, Journal of clinical oncology, 16(5), 1998, pp. 1736-1742
Authors:
SCHIMMER AD
STEWART AK
KEATING A
MACKINNON J
CRUMP M
SUTTON DM
SHEPHERD FA
MEHARCHAND J
Citation: Ad. Schimmer et al., SAFETY OF THERAPEUTIC ANTICOAGULATION IN PATIENTS WITH MULTIPLE-MYELOMA RECEIVING AUTOLOGOUS STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 22(5), 1998, pp. 491-494
Authors:
ABRATT RP
SANDLER A
CRINO L
STEWARD WP
SHEPHERD FA
GREEN MR
NGUYEN B
PETERS GJ
Citation: Rp. Abratt et al., COMBINED CISPLATIN AND GEMCITABINE FOR NONSMALL CELL LUNG-CANCER - INFLUENCE OF SCHEDULING ON TOXICITY AND DRUG-DELIVERY, Seminars in oncology, 25(4), 1998, pp. 35-43
Authors:
SHEPHERD FA
EISENHAUER E
Citation: Fa. Shepherd et E. Eisenhauer, IFOSFAMIDE AND PACLITAXEL COMBINATIONS FOR THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(1), 1998, pp. 2-7
Authors:
RAPPAPORT DC
CHAMBERLAIN DW
SHEPHERD FA
HUTCHEON MA
Citation: Dc. Rappaport et al., LYMPHOPROLIFERATIVE DISORDERS AFTER LUNG TRANSPLANTATION - IMAGING FEATURES, Radiology, 206(2), 1998, pp. 519-524
Authors:
SHEPHERD FA
JOHNSTON MR
PAYNE D
BURKES R
DESLAURIERS J
CORMIER Y
DEBEDOYA LD
OTTAWAY J
JAMES K
ZEE B
Citation: Fa. Shepherd et al., RANDOMIZED STUDY OF CHEMOTHERAPY AND SURGERY VERSUS RADIOTHERAPY FOR STAGE IIIA NON-SMALL-CELL LUNG-CANCER - A NATIONAL-CANCER-INSTITUTE OFCANADA CLINICAL-TRIALS GROUP-STUDY, British Journal of Cancer, 78(5), 1998, pp. 683-685
Authors:
TUCKER MA
MURRAY N
SHAW EG
ETTINGER DS
MABRY M
HUBER MH
FELD R
SHEPHERD FA
JOHNSON DH
GRANT SC
AISNER J
JOHNSON BE
Citation: Ma. Tucker et al., 2ND PRIMARY CANCERS RELATED TO SMOKING AND TREATMENT OF SMALL-CELL LUNG-CANCER, Journal of the National Cancer Institute, 89(23), 1997, pp. 1782-1788
Authors:
EVANS WK
NEWMAN T
GRAHAM I
RUSTHOVEN JJ
LOGAN D
SHEPHERD FA
CHAMBERLAIN D
Citation: Wk. Evans et al., LUNG-CANCER PRACTICE GUIDELINES - LESSONS LEARNED AND ISSUES ADDRESSED BY THE ONTARIO-LUNG-CANCER-DISEASE-SITE-GROUP, Journal of clinical oncology, 15(9), 1997, pp. 3049-3059
Authors:
SHEPHERD FA
MAHER E
CARDELLA C
COLE E
GREIG P
WADE JA
LEVY G
Citation: Fa. Shepherd et al., TREATMENT OF KAPOSIS-SARCOMA AFTER SOLID-ORGAN TRANSPLANTATION, Journal of clinical oncology, 15(6), 1997, pp. 2371-2377
Authors:
STEWART DJ
EVANS WK
SHEPHERD FA
WILSON KS
PRITCHARD KI
TRUDEAU ME
WILSON JJ
MARTZ K
Citation: Dj. Stewart et al., CYCLOPHOSPHAMIDE AND FLUOROURACIL COMBINED WITH MITOXANTRONE VERSUS DOXORUBICIN FOR BREAST-CANCER - SUPERIORITY OF DOXORUBICIN, Journal of clinical oncology, 15(5), 1997, pp. 1897-1905
Authors:
SHEPHERD FA
Citation: Fa. Shepherd, MORE IS BETTER BUT .... HOW IS BEST - ARE MILLIGRAMS OVER HOURS BETTER THAN GRAMS OVER MINUTES - THE CASE OF GEMCITABINE - REPLY, Journal of clinical oncology, 15(5), 1997, pp. 2173-2174
Authors:
PERRY MC
DESLAURIERS J
ALBAIN KS
CHOI NC
DEPIERRE A
JOHNSTON MR
LACQUET LK
PAYNE DG
PUTNAM JB
SCULIER JP
SHEPHERD FA
Citation: Mc. Perry et al., INDUCTION TREATMENT FOR RESECTABLE NON-SMALL-CELL LUNG-CANCER, Lung cancer, 17, 1997, pp. 15-18
Authors:
SHEPHERD FA
Citation: Fa. Shepherd, ALTERNATIVES TO CHEMOTHERAPY AND RADIOTHERAPY AS ADJUVANT TREATMENT FOR LUNG-CANCER, Lung cancer, 17, 1997, pp. 121-136
Authors:
SHEPHERD FA
CORMIER Y
BURKES R
EVANS WK
GOSS G
KLIMO P
FELD R
TAYLOR M
Citation: Fa. Shepherd et al., PHASE-II TRIAL OF GEMCITABINE AND WEEKLY CISPLATIN FOR ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(3), 1997, pp. 827-830
Authors:
SHEPHERD FA
ABRATT RP
ANDERSON H
GATZEMEIER U
ANGLIN G
IGLESIAS J
Citation: Fa. Shepherd et al., GEMCITABINE IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(2), 1997, pp. 50-55
Authors:
SCHIMMER AD
MACKINNON J
MEHARCHAND J
KEATING A
CRUMP RM
SUTTON DM
SHEPHERD FA
STEWART AK
Citation: Ad. Schimmer et al., SAFETY OF THERAPEUTIC ANTICOAGULATION IN PATIENTS WITH MULTIPLE-MYELOMA RECEIVING AUTOLOGOUS STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 4387-4387
Authors:
GATZEMEIER U
SHEPHERD FA
LECHEVALIER T
WEYNANTS P
COTTIER B
GROEN HJM
ROSSO R
MATTSON K
CORTESFUNES H
TONATO M
BURKES RL
GOTTFRIED M
VOI M
Citation: U. Gatzemeier et al., ACTIVITY OF GEMCITABINE IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER -A MULTICENTER, EXTENDED PHASE-II STUDY, European journal of cancer, 32A(2), 1996, pp. 243-248
Authors:
SHEPHERD FA
LATREILLE J
CRUMP M
STEWART D
TOMIAK E
EISENHAUER E
FISHER B
Citation: Fa. Shepherd et al., PHASE-I STUDY OF PACLITAXEL (TAXOL(TM)) AND IFOSFAMIDE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - A STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP, Annals of oncology, 7(3), 1996, pp. 311-313
Authors:
SHEPHERD FA
BURKES R
CORMIER Y
CRUMP M
FELD R
STRACK T
SCHULZ M
Citation: Fa. Shepherd et al., PHASE-I DOSE-ESCALATION TRIAL OF GEMCITABINE AND CISPLATIN FOR ADVANCED NON-SMALL-CELL LUNG-CANCER - USEFULNESS OF MATHEMATIC MODELING TO DETERMINE MAXIMUM-TOLERABLE DOSE, Journal of clinical oncology, 14(5), 1996, pp. 1656-1662
Authors:
SIU LL
SHEPHERD FA
MURRAY N
FELD R
PATER J
ZEE B
Citation: Ll. Siu et al., INFLUENCE OF AGE ON THE TREATMENT OF LIMITED-STAGE SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(3), 1996, pp. 821-828
Authors:
LIU G
CRUMP M
GOSS PE
DANCEY J
SHEPHERD FA
Citation: G. Liu et al., PROSPECTIVE COMPARISON OF THE SCLEROSING AGENTS DOXYCYCLINE AND BLEOMYCIN FOR THE PRIMARY MANAGEMENT OF MALIGNANT PERICARDIAL-EFFUSION AND CARDIAC-TAMPONADE, Journal of clinical oncology, 14(12), 1996, pp. 3141-3147
Authors:
SHEPHERD FA
BURKES R
CORMIER Y
CRUMP M
FELD R
STRACK T
Citation: Fa. Shepherd et al., PHASE-I TRIAL OF GEMCITABINE AND CISPLATIN IN ADVANCED NON-SMALL-CELLLUNG-CANCER - A PRELIMINARY-REPORT, Lung cancer, 14(1), 1996, pp. 135-144
Authors:
SHEPHERD FA
LATREILLE J
PAUL K
EISENHAUER E
Citation: Fa. Shepherd et al., PHASE-I DOSE-ESCALATION TRIAL OF PACLITAXEL AND IFOSFAMIDE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 23(6), 1996, pp. 84-90
Authors:
CARNEY DN
BUNN PA
BELANI CP",GIACCONE,"SHEPHERD FA
CALVERT AH
COMIS RL
SPLINTER TAW
ETTINGER DS
JOHNSON DH
LANGER CJ
GRECO FA
HAINSWORTH JD
BONOMI P
CURRAN WJ
CHOY H
GLANTZ MJ
Citation: Dn. Carney et al., DISCUSSION - LUNG-CANCER, Seminars in oncology, 23(6), 1996, pp. 140-147
Authors:
SHEPHERD FA
BURKES RL
CORMIER Y
CRUMP M
FELD R
STRACK T
SCHULZ M
Citation: Fa. Shepherd et al., FINAL RESULTS OF THE CANADIAN PHASE-I DOSE-ESCALATION TRIAL OF GEMCITABINE AND CISPLATIN FOR ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 23(5), 1996, pp. 48-54